| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235037 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 9 Pages |
Abstract
Celastrol sensitized PC-3 cells to radiation both in vitro and in vivo by impairing DNA damage processing and augmenting apoptosis. Celastrol might represent a promising new adjuvant regimen for the treatment of hormone-refractory prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yao Ph.D., Jeffrey T. DeSano, Yang Ph.D., Qing M.D., Ph.D., Mats Ph.D., Theodore S. M.D., Ph.D., Liang M.D., Ph.D.,